The reduction in price target by JP Morgan, despite maintaining an Overweight rating, could lead to a negative short-term sentiment among investors, potentially causing a decrease in Endava's stock price. The adjustment reflects a reassessment of Endava's valuation, possibly due to market conditions or company performance, which investors may interpret as a sign of caution.